Product Specification
Species |
Human |
Accession |
P01133 |
Amino Acid Sequence |
Asn971-Arg1023, with an N-terminal Met
MNSDSECPLS HDGYCLHDGV CMYIEALDKY ACNCVVGYIGERCQYRDLKW WELR
|
Expression System |
E.coli |
Molecular Weight |
7kDa (Reducing) |
Purity |
>95% by SDS-PAGE |
Endotoxin |
<0.2EU/μg |
Conjugation |
Unconjugated |
Tag |
No Tag |
Physical Appearance |
Lyophilized Powder |
Storage Buffer |
PBS, pH7.4 |
Reconstitution |
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage |
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
|
Background
Epidermal Growth Factor (EGF) is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Epidermal growth factor (EGF) binds to epidermal growth factor receptor and stimulates an intracellular signal transduction cascade, leading to activation of genes that regulate cell proliferation, angiogenesis, motility, and metastasis. Epidermal growth factor (EGF) mRNA and protein are expressed in a number of adult tissues, especially in epithelial cells in the gastrointestinal tract. Predominant sites of synthesis of this peptide are the submandibular glands, the Brunner glands in the small intestine and the kidney.